PD-1 immune checkpoint blockade may be viable for the prevention and treatment of elderly patients with POCD [Letter]
Penghui Wei, Fan Yang, Jianjun LiDepartment of Anesthesiology, Qilu Hospital of Shandong University (Qingdao), Qingdao 266035, People’s Republic of ChinaDear EditorRecently, we read with great interest the well-written review article published in the November 8, 2018 edition of th...
Guardado en:
Autores principales: | Wei P, Yang F, Li J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1fd7baa5e26b44fb94cdd3f6f42c9888 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immune checkpoint blockade in the treatment of malignant tumor: current statue and future strategies
por: Wenwen Yang, et al.
Publicado: (2021) -
Posttranslational Modifications in PD-L1 Turnover and Function: From Cradle to Grave
por: Xinfang Yu, et al.
Publicado: (2021) -
Class IIa HDAC Downregulation Contributes to Surgery-Induced Cognitive Impairment Through HMGB1-Mediated Inflammatory Response in the Hippocampi of Aged Mice
por: Huang C, et al.
Publicado: (2021) -
Postoperative cognitive dysfunction – current preventive strategies
por: Kotekar N, et al.
Publicado: (2018) -
A Noradrenergic Lesion Attenuates Surgery-Induced Cognitive Impairment in Rats by Suppressing Neuroinflammation
por: Jiayu Wang, et al.
Publicado: (2021)